Comparative Pharmacology
Head-to-head clinical analysis: COLD CAPSULE IV versus COLD CAPSULE V.
Peer-Reviewed Evidence
Head-to-head clinical analysis: COLD CAPSULE IV versus COLD CAPSULE V.
COLD CAPSULE IV vs COLD CAPSULE V
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Combination of antihistamine (chlorpheniramine) blocking H1 receptors, nasal decongestant (phenylephrine) causing vasoconstriction, and analgesic/antipyretic (acetaminophen) inhibiting COX enzymes in CNS.
Combination of acetaminophen (analgesic/antipyretic via COX inhibition in CNS), phenylephrine (alpha-1 adrenergic agonist causing vasoconstriction), and dextromethorphan (NMDA receptor antagonist and sigma-1 agonist suppressing cough).
1-2 capsules orally every 4-6 hours as needed for symptoms; maximum 12 capsules per day.
Chlorpheniramine 4 mg orally every 4-6 hours, not to exceed 24 mg/day; Dextromethorphan 15-30 mg orally every 6-8 hours, not to exceed 120 mg/day; Phenylephrine 10 mg orally every 4 hours, not to exceed 60 mg/day.
None Documented
None Documented
Acetaminophen: 2-3 hours (prolonged in hepatic impairment). Pseudoephedrine: 5-8 hours (alkaline urine increases half-life). Dextromethorphan: 3-5 hours (CYP2D6 poor metabolizers: up to 20 hours).
4-6 hours; prolonged to 8-12 hours in hepatic impairment; no accumulation with q6h dosing in normal renal function.
Renal elimination of acetaminophen metabolites (primarily glucuronide and sulfate conjugates) accounts for ~85-90% of the dose; unchanged drug <5%. Pseudoephedrine and dextromethorphan are primarily excreted renally (70-90% and 50-80% respectively, with some biliary/fecal).
Renal: 70% (inactive metabolites), Fecal: 25% (unabsorbed drug), Biliary: 5%.
Category C
Category C
Cold & Cough Combination
Cold & Cough Combination